Effectiveness of Digoxin in Reducing One-Year Mortality in Chronic Heart Failure in the Digitalis Investigation Group Trial
- 27 October 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 103 (1) , 82-87
- https://doi.org/10.1016/j.amjcard.2008.06.068
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: A propensity-matched study of the DIG trialInternational Journal of Cardiology, 2007
- Digitalis Treatment Decreases Mortality and Morbidity in Heart Failure PatientsCardiology, 2006
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart FailureCirculation, 2006
- Contemporary Use of Digoxin in the Management of Cardiovascular DisordersCirculation, 2006
- Rehabilitating digoxinThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2005
- Was it Digoxin Toxicity?…Very LikelyJournal of Cardiac Failure, 2005
- Determination of vital status at the end of the DIG trialControlled Clinical Trials, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The serum digoxin test and digoxin toxicity: a Bayesian approach to decision making.Circulation, 1981
- The Inotropic Effects of Digoxin in HyperkalemiaCirculation, 1973